Companies / Financials
FDS
FactSet
Financial Exchanges & Data
Financial Exchanges & DataAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health74
Growth46
Profitability82
Cash generationn/a
Balance sheetn/a
Dilution control93
Key ratios and five-year financials
Latest quarter revenue YoY (2026-05-31)6.4%Revenue growth (FY)6.7%Revenue CAGR (3y)5.9%Gross margin50.6%Operating margin28.3%Net margin21.5%Free cash flow margin28.6%R&D / revenue14.0%Stock comp / revenue3.4%Net debt / operating cash flow1.99xCurrent ratio0.60Diluted share count change-4.6%
| Fiscal year ending | FY 2022-08 | FY 2023-08 | FY 2024-08 | FY 2025-08 | FY 2026-08 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.1B | $2.2B | $2.3B | $2.5B |
| Gross profit | $973M | $1.1B | $1.2B | $1.2B | $1.3B |
| Operating income | $475M | $629M | $701M | $748M | $700M |
| Net income | $397M | $468M | $537M | $597M | $533M |
| Operating cash flow | $538M | $646M | $700M | $726M | $822M |
| Capital expenditure | $51M | $61M | $86M | $109M | $115M |
| Free cash flow | $487M | $585M | $615M | $617M | $707M |
| R&D | $255M | $267M | $265M | $301M | $346M |
| Stock-based comp | $56M | $62M | $64M | $61M | $84M |
| Buybacks | $19M | $177M | $235M | $300M | $644M |
| Dividends | $126M | $139M | $151M | $160M | $164M |
| Cash | $503M | $425M | $423M | $338M | $233M |
| Total debt | $2.0B | $1.6B | $1.5B | $1.4B | $1.9B |
| Equity | $1.3B | $1.6B | $1.9B | $2.2B | $2.0B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.